Ignite Creation Date:
2024-05-06 @ 1:59 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01943864
Status:
COMPLETED
Last Update Posted:
2017-05-31
First Post:
2013-09-12
Brief Title:
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline